Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) — Cash Flow-to-Debt Ratio
Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) has a Cash Flow-to-Debt Ratio of 0.37x as of September 2025, meaning its operating cash flow of CN¥281.88 Million could theoretically repay 0% of its total liabilities (CN¥757.69 Million) in one year. See Shaanxi Meibang Pharmaceutical Group Co financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shaanxi Meibang Pharmaceutical Group Co Ltd Cash Flow-to-Debt Ratio (2017–2024)
Historical debt coverage capacity for Shaanxi Meibang Pharmaceutical Group Co Ltd across 8 annual periods. For the full cash flow conversion analysis, see how efficiently does Shaanxi Meibang Pharmaceutical Group Co generate cash.
Annual Cash Flow-to-Debt Ratio for Shaanxi Meibang Pharmaceutical Group Co Ltd (2017–2024)
Year-by-year debt coverage analysis for Shaanxi Meibang Pharmaceutical Group Co Ltd. Check Shaanxi Meibang Pharmaceutical Group Co cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.38x | CN¥280.40 Million | CN¥737.37 Million | ▼ -34.4% |
| 2023 | 0.58x | CN¥334.79 Million | CN¥577.84 Million | ▲ +117.3% |
| 2022 | 0.27x | CN¥126.41 Million | CN¥474.14 Million | ▲ +221.7% |
| 2021 | -0.22x | CN¥-108.75 Million | CN¥496.43 Million | ▼ -198.5% |
| 2020 | 0.22x | CN¥74.88 Million | CN¥336.50 Million | ▼ -48.8% |
| 2019 | 0.43x | CN¥128.45 Million | CN¥295.34 Million | ▲ +693.5% |
| 2018 | 0.05x | CN¥16.96 Million | CN¥309.40 Million | ▼ -38.6% |
| 2017 | 0.09x | CN¥29.41 Million | CN¥329.23 Million | — |